Herb-drug interactions

Lancet

Volumn 355, Issue 9198, 2000, Pages 134-138

  Fugh Berman, Adriane ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; AYURVEDIC DRUG; BETEL EXTRACT; CASCARA; CORTICOSTEROID; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GUAR GUM; ISPAGULA; NEUROLEPTIC AGENT; PHENYTOIN; PREDNISOLONE; SENNA EXTRACT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN; XIAO CHAI HU TANG; YOHIMBINE;

BLEEDING; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG POTENTIATION; EXTRAPYRAMIDAL SYNDROME; GARLIC; GINKGO BILOBA; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; MANIA; PRIORITY JOURNAL; SALVIA MILTIORRHIZA; SEROTONIN SYNDROME; SHORT SURVEY;

ALLIUM SATIVUM; ANGELICA SINENSIS; GINKGO BILOBA; HYPERICUM PERFORATUM; SALVIA MILTIORHIZA;

EID: 0034620261     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)06457-0     Document Type: Review

References (65)

1. Bailey C.J., Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 12:1989;553-564.
2. Doucet J., Chassagne P., Trivalle C.et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc. 44:1996;944-948.
3. Fugh-Berman A., Cott J.M. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med. 61:1999;712-728.
4. Cott J.M., Fugh-Berman A. Is St John's Wort (Hypericum perforatum) an effective antidepressant? J Nerv Ment Dis. 186:1998;500-501.
5. Deahl M. Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord. 4:1989;330-333.
6. Taylor R.F.H., Al-Jarad N., John L.M.E. Betel-nut chewing and asthma. Lancet. 339:1992;1134-1136.
7. Hakas J.F. Topical capsaicin induces cough in patient receiving ACE inhibitor. Ann Allergy. 65:1990;322.
8. Bouraoui A., Toum A., Bouchoucha S.et al. Influence de l'alimentation épicéé et piquante sur l'absorption de la théophylline. Thérapie. 41:1986;467-471.
9. Tam L.S., Chan T.Y.K., Leung W.K., Critchley J.A.J.H. Warfarin interactions with Chinese traditional medicines; danshen and methyl salicylate medicated oil. Aust NZ J Med. 25:1995;257.
10. Yu C.M., Chan J.C.N., Sanderson J.E. Chinese herbs and warfarin potentiation by 'danshen'. J Intern Med. 41:1997;337-339.
11. Izzat M.B., Yim A.P.C., El-Zufari M.H. A taste of Chinese medicine. Ann Thorac Surg. 66:1998;941-942.
12. Chan K., Lo A.C., Yeung J.H., Woo K.S. The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol. 47:1995;402-406.
13. Cheng T.O. Warfarin danshen interaction. Ann Thorac Surg. 67:1999;892-896.
14. Shaw D., Leon C., Kolev S., Murray V. Traditional remedies and food supplements: a five year toxicological study (1991-1995). Drug Saf. 17:1997;342-356.
15. Page R.L., Lawrence J.D. Potentiation of warfarin by dong quai. Pharmacotherapy. 19:1999;870-876.
16. Ellis G.R., Stephens M.R. Untitled (photograph and brief case report). BMJ. 319:1999;650.
17. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J. 155:1996;293-295.
18. De Smet P.A.G.M., D'Arcy P.F. Drug interactions with herbal and other non-toxic remedies. D'Arcy P.F., McElnay J.C., Welling P.G. Mechanisms of drug interactions. 1996;Springer-Verlag, Berlin.
19. Burnham B.E. Garlic as a possible risk for postoperative bleeding. Plast Reconstruc Surg. 95:1995;213.
20. German K., Kumar U., Blackford H.N. Garlic and the risk of TURP bleeding. Br J Urol. 76:1995;518.
21. Rose K.D., Croissant P.D., Parliament C.F., Levin M.B. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic consumption: a case report. Neurosurgery. 26:1990;880-882.
22. Rosenblatt M., Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med. 336:1997;1108.
23. Lamant V., Mauco G., Braquet P., Chap H., Douste-Blazy L. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol. 36:1987;2749-2752.
24. Chung K.F., McCusker M., Page C.P.et al. Effect of a ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet. I:1987;248-250.
25. Rowin J., Lewis S.L. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 46:1996;1775-1776.
26. Vale S. Subarachnoid haemorrhage associated with ginkgo biloba. Lancet. 352:1998;36.
27. Gilbert G.J. Ginkgo biloba. Neurology. 48:1997;1137.
28. Matthews M.K. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology. 50:1998;1933.
29. Janetzky K., Morreale A.P. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm. 54:1997;692-693.
30. Zhu M., Chan K.W., Ng L.S.et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol. 51:1999;175-180.
31. Shader R.I., Greenblatt D.J. Phenelzine and the dream machine - ramblings and reflections. J Clin Psychopharmacol. 5:1985;65.
32. Jones B.D., Runikis A.M. Interaction of ginseng with phenelzine. J Clin Psychopharmacol. 7:1987;201-202.
33. Lee F.C., Ko J.H., Park J.K., Lee J.S. Effects of Panax ginseng on blood alcohol clearance in man. Clin Exp Pharmacol Physiol. 14:1987;543-546.
34. Aslam M., Stockley I.H. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet. I:1979;607.
35. Leatherdale B.A., Panesar R.K., Singh G.et al. Improvement in glucose tolerance due to Momordica charantia (karela). BMJ. 282:1981;1823-1824.
36. Chen M.-F., Shimada F., Kato H.et al. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn. 38:1991;167-175.
37. Chen M.-F., Shimada F., Kato H.et al. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinol Jpn. 37:1990;331-341.
38. Teelucksingh S., Mackie A.D.R., Burt D.et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 335:1990;1060-1063.
39. De Klerk G.J., Nieuwenhuis M.G., Beutle J.J. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ. 314:1997;731-732.
40. Bernardi M., D'Intino P.E., Trevisani F.et al. Effects of prolonged graded doses of licorice by healthy volunteers. Life Sci. 55:1994;863-872.
41. Perlman B.B. Interaction between lithium salts and ispaghula husk. Lancet. 335:1990;416.
42. Gordon J.B. SSRIs and St John's wort: possible toxicity? Am Fam Phys. 57:1998;950.
43. Demott K. St John's wort tied to serotonin syndrome. Clin Psychiatry News. 26:1998;28.
44. Lantz M.S., Buchalter E., Giambanco V. St John's Wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatr Neurol. 12:1999;7-10.
45. Nebel A., Schneider B.J., Baker R.K., Kroll D.J. Potential metabolic interaction between St John's Wort and theophylline. Ann Pharmacother. 33:1999;502.
46. Johne A., Brockmöller J., Bauer S.et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther. 66:1999;338-345.
47. Ernst E. Second thoughts about safety of St John's wort. Lancet. 354:1999;2014-2015.
48. Maurer A., Johne A., Bauer S.et al. Interaction of St John's wort extract with phenprocoumon. Eur J Clin Pharmacol. 55:1999;22.
49. Bon S., Hartmann K., Kuhn M. Schweitzer Apothekerzeitung. 16:1999;535-536.
50. Homma M., Oka K., Ikeshima K.et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol. 47:1995;687-692.
51. Dandekar U.P., Chandra R.S., Dalvi S.et al. Analysis of clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation. J Ethnopharm. 35:1992;285-288.
52. Mustapha A., Yakasai I.A., Aguye I.A. Effect of Tamarindus indica L on the bioavailability of aspirin in healthy human volunteers. Eur Drug Metab Pharmacokinet. 21:1996;223-226.
53. Bos R., Woerdenberg H.J., De Smet P.A.G.M., Scheffer J.J.C. Valeriana species. De Smet P.A.G.M., Keller K., Hansel R., Chandler R.F. Adverse effects of herbal drugs, vol 3. 1997;165-180 Springer, Berlin.
54. Lacombiez L., Bensimon G., Isnard F.et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypertension induced by clomipramine. Clin Pharmacol Ther. 45:1989;241-251.
55. De Smet P.A.G.M. Yohimbe alkaloids - general discussion. De Smet P.A.G.M., Keller K., Hansel R., Chandler R.F. Adverse effects of herbal drugs, volume 3. 1997;181-206 Springer, Berlin.
56. But P.P.-H. Herbal poisoning caused by adulterants or erroneous substitutes. J Trop Med Hyg. 97:1994;371-374.
57. Koren G., Randor S., Martin S., Danneman D. Maternal ginseng use associated with neonatal androgenization. JAMA. 264:1990;2866.
58. Awang D.V.C. Maternal use of ginseng and neonatal androgenization. JAMA. 266:1991;363.
59. Huang W.F., Wen K.C., Hsiao M-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 37:1997;344-350.
60. Gertner E., Marshall P.S., Filandrinos D.et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum. 38:1995;614-617.
61. Vander Stricht B.I., Parvais O.E., Vanhaelen-Fastre R.J. Remedies may contain cocktail of active drugs. BMJ. 308:1994;1162.
62. Ko R.J. Adulterants in Asian patent medicines. N Engl J Med. 339:1998;847.
63. Eisenberg D.M., Davis R.B., Ettner S.L.et al. Trends in alternative medicine use in the United States, 1990-97. JAMA. 280:1998;1569-1575.
64. Barnes J., Mills S.Y., Abbott N.C.et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face to face interviews with 515 users of herbal remedies. Br J Clin Pharmacol. 45:1998;496-500.
65. Westendorf J. Anthranoid derivatives - general discussion. In: De Smet PAGM, Keller K, Hansel R, Chandler RF. Adverse effects of herbal drugs, vol 2: 105-108.